StockTipsArenaBeta

BUY Sai Life Sciences — Ashish Kyal, Waves Strategy Advisors

BUYSai Life Sciences
Sai Life Sciences share price target & all analyst calls

byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))20 Aug 2026via ET Now (Live)

Entry₹1,478.2Inferred
Target₹1,600
Total upside +8.24% (call closed)
Stop loss₹1,420-3.94% risk
At expiry₹1,592.72 Sept 2026, 3:30 pm
Expired+7.75%
Follow Ashish Kyal for new calls(24% target hit, 159 closed calls)Get alertsWatch SAILIFE for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
5 supporting2 neutral1 opposing
Supports the BUY call (5)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·2 Sept · today

SAI LIFE SCIENCES Share Price: Fresh 52-Week High Analysis

NewsGoogle News·27 Aug · 6d ago

(opens in new tab)

Jefferies rates 5 CRDMO stocks ‘Buy’ with up to 20% upside potential

NewsGoogle News·27 Aug · 6d ago

(opens in new tab)

SAI LIFE SCIENCES LIMITED Share Price Hits One-Year High

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)

SAI LIFE SCIENCES LIMITED Share Price Today: 3.06% Gain

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Sai Life Sciences files FY26 BRSR and ESG Databook on August 25

NewsGoogle News·25 Aug · 1w ago

(opens in new tab)

Sai Life Sciences schedules 27th AGM for September 17, 2026

NewsGoogle News·24 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

Sai Life Sciences Share Price Tanks Over 6% Even As Q1 Profit Rises 21%; Revenue Rises To Rs 554 Crore

NewsNdtv-Profit·7 Aug · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sai Life Sciences

All analyst calls on Sai Life Sciences

More from Ashish Kyal, Waves Strategy Advisors

Every call and its outcome